FILTER
FILTERED INTERVIEW RESULTS
Hüseyin Yılmaz & Ece Öztürk
MANAGING DIRECTOR, GENERAL MANAGER & BUSINESS STRATEGY CONSULTANT, HASBIOTECH
Founded in 2009, Hasbiotech is driven to create and manufacture an original Turkish medicine starting from scratch and is establishing a manufacturing site for local production of biotechnological products.
Ahmet Altug Oguz
CEO, TÜM EKİP ILAÇ
Tüm Ekip Pharmaceuticals was established in 2000 and is a specialized injectable pharmaceutical producer, with capability to produce seven different sterile forms.
Arun D. Joshi
CHAIRMAN AND MANAGING DIRECTOR, SURYA LIFE SCIENCES
Established in the year 2002, Surya Life Sciences is a manufacturer, exporter, and supplier of a wide assortment of bulk drug intermediates and fine API chemicals.
Paolo Russolo
PRESIDENT, ASCHIMFARMA
Aschimfarma represents Italian producers of pharmaceutical ingredients and helps advise them on regulations across the world.
Ersin Erfa
GENERAL MANAGER, CENTURION PHARMA
Centurion Pharma was founded in 1979, and today imports products for the treatment of rare diseases as well as biological, biotechnological and hospital products. Centurion has also taken steps to develop and manufacture products locally by establishing an R&D Department in 2011.
Dr. Ayça Sezer
MANAGING DIRECTOR, CORPORATE BUSINESS DEVELOPMENT DIRECTOR, SANTA FARMA
Santa Farma was established in 1944 and has become known as a leading company capable of manufacturing the highest volume in a single shift in Turkey.
Cem Öztürk
COUNTRY MANAGER, SANOFI
Sanofi has a diversified portfolio, ranging from innovative medicines including rare diseases, immunology, diabetes and cardiovascular to consumer healthcare products and vaccines.
Prof. Dr. Berrin Erdag
CHIEF SENIOR RESEARCHER, TUBITAK MAM, GENETIC ENGINEERING AND BIOTECHNOLOGY INSTITUTE (GEBI)
The Genetic Engineering and Biotechnology Institute (GEBI) conducts researches and develops technologies in the field of genetic engineering and biotechnology with high added value by taking into consideration the developments in the world and the needs of the public and industrial sectors in Turkey.
Mehmet Goker
CEO, TR-PHARM
TR-PHARM, founded in 2013, is a marketer of pharmaceuticals and biopharmaceuticals with a focus on high-tech R&D and the ambition to gain global recognition in bringing high-quality and cost-effective solutions in the healthcare industry.
Philipp Haas
CHAIRMAN & CEO, DEVA HOLDING
Active since 1958, DEVA is a generics company with approximately 600 products ranging from APIs, formulations, sterile injectables and ampoules, BFS eye drops and animal health products.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
